Travere Therapeutics Inc
NASDAQ:TVTX

Watchlist Manager
Travere Therapeutics Inc Logo
Travere Therapeutics Inc
NASDAQ:TVTX
Watchlist
Price: 6.34 USD -3.35% Market Closed
Updated: May 24, 2024

Revenue Breakdown

Breakdown by Geography
Travere Therapeutics Inc

Not Available

Breakdown by Segments
Travere Therapeutics Inc

Total Revenue: 145.2m USD
100%
Net Product Sales: 127.5m USD
87.8%
Filspari: 29.2m USD
20.1%
License And Collaboration Revenue: 17.7m USD
12.2%
Clinical Development Activity: 14.4m USD
9.9%
Active Pharmaceutical Ingredient: 3.3m USD
2.3%
Show More
Show Less

See Also

Discover More